Last reviewed · How we verify
Sodium hypochlorite 5.25% — Competitive Intelligence Brief
phase 3
Oxidizing disinfectant/antiseptic
Infectious Disease / Disinfection
Small molecule
Live · refreshed every 30 min
Target snapshot
Sodium hypochlorite 5.25% (Sodium hypochlorite 5.25%) — Dow University of Health Sciences. Sodium hypochlorite releases hypochlorous acid, which oxidizes and denatures bacterial and viral proteins, disrupting cell membranes and nucleic acids to exert broad-spectrum antimicrobial activity.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sodium hypochlorite 5.25% TARGET | Sodium hypochlorite 5.25% | Dow University of Health Sciences | phase 3 | Oxidizing disinfectant/antiseptic |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Oxidizing disinfectant/antiseptic class)
- Dow University of Health Sciences · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sodium hypochlorite 5.25% CI watch — RSS
- Sodium hypochlorite 5.25% CI watch — Atom
- Sodium hypochlorite 5.25% CI watch — JSON
- Sodium hypochlorite 5.25% alone — RSS
- Whole Oxidizing disinfectant/antiseptic class — RSS
Cite this brief
Drug Landscape (2026). Sodium hypochlorite 5.25% — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-hypochlorite-5-25. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing